# Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR

> **NCT07434661** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Meshalkin Research Institute of Pathology of Circulation** · enrollment: 120 (estimated)

## Conditions studied

- Valve Disease, Heart
- Atrial Fibrillation (AF)
- Valve Replacement Surgery
- Aortic Valve Surgery
- Mitral Valve Annuloplasty
- Mitral Valve Repair
- Mitral Valve Surgery

## Interventions

- **DRUG:** Apixaban
- **DRUG:** Warfarin

## Key facts

- **NCT ID:** NCT07434661
- **Lead sponsor:** Meshalkin Research Institute of Pathology of Circulation
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2028-01
- **Final completion:** 2029-01
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07434661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07434661, "Apixaban VS Warfarin in AF Pts First Three Months After Repair or BIO AVR MVR". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07434661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*